V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270013633 | 270009237 | 1.78 | 77 | Palliative (P) | 2014-09-18 | 2014-10-03 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270015338 | CETUXIMAB + IRINOTECAN + MDG |
| 270013634 | 270009240 | 1.86 | 102.7 | Curative (C) | 2016-04-21 | 2016-04-21 | OEPA | N | Y | 270015339 | OEPA |
| 270013635 | 270009242 | 1.64 | 70 | Curative (C) | 2015-03-13 | 2015-03-22 | ESHAP | N | N | 270015342 | ESHAP |
| 270013636 | 270009246 | 1.81 | 63.7 | Curative (C) | 2013-05-17 | 2013-05-17 | HD EuroNet-PHL-C1 OEPA | 2 | N | 270015350 | OEPA |
| 270013637 | 270019179 | 1.84 | null | Curative (C) | 2013-04-23 | 2013-05-22 | LEAM | N | N | 270015351 | LEAM |
| 270013638 | 270009247 | 1.64 | 33.3 | Curative (C) | 2017-08-25 | 2017-08-25 | ESHAP | 02 | N | 270015351 | ESHAP |
| 270013639 | 270009248 | null | 84.8 | Disease modification (D) | 2017-03-02 | 2017-03-02 | BEAM | N | N | 270015354 | BEAM |
| 270013640 | 270009248 | 1.75 | 57.2 | Palliative (P) | 2016-12-20 | 2016-12-24 | HD EuroNet-PHL-C1 OEPA | N | N | 270015354 | OEPA |
| 270013641 | 270009248 | 1.83 | 100.1 | Curative (C) | 2016-05-11 | 2017-08-29 | LEAM | 2 | N | 270015354 | LEAM |
| 270013642 | 270009250 | 1.61 | 129.8 | Curative (C) | 2013-06-13 | 2013-06-13 | LEAM | N | N | 270015359 | LEAM |
| 270013643 | 270009250 | 1.6 | 91.3 | Curative (C) | 2016-04-09 | 2016-04-09 | BEAM | 02 | null | 270015359 | BEAM |
| 270013644 | 270009250 | 1.5 | 92 | Palliative (P) | 2017-05-10 | 2017-05-18 | OEPA | 2 | N | 270015359 | OEPA |
| 270013645 | 270009251 | 1.69 | 54.2 | Curative (C) | 2018-03-29 | 2018-03-29 | BEAM | N | N | 270015366 | BEAM |
| 270013646 | 270009254 | 1.64 | 108.5 | Curative (C) | 2017-01-20 | 2017-01-20 | Rituximab | 2 | N | 270015370 | RITUXIMAB |
| 270013647 | 270009255 | 1.8 | 70 | Curative (C) | 2017-04-18 | 2017-04-24 | ESHAP | N | N | 270015372 | ESHAP |
| 270013648 | 270014323 | 1.4 | 110 | Curative (C) | 2016-03-03 | 2016-03-09 | BEAM | 02 | N | 270015374 | BEAM |
| 270013649 | 270014323 | 1.82 | 80.8 | Palliative (P) | 2017-12-05 | 2017-12-18 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270015374 | CETUXIMAB + IRINOTECAN + MDG |
| 270013650 | 270014323 | 1.7 | 57.6 | Curative (C) | 2015-07-16 | 2015-07-16 | BEAM | N | N | 270015374 | BEAM |
| 270013651 | 270014323 | 1.75 | 90.8 | Curative (C) | null | 2016-05-19 | ESHAP | null | N | 270015374 | ESHAP |
| 270013652 | 270014323 | 1.65 | 48 | Curative (C) | 2018-02-26 | 2018-03-02 | ESHAP | 02 | N | 270015374 | ESHAP |
| 270013653 | 270014324 | 1.85 | 86.9 | null | 2014-08-04 | 2014-08-18 | Cisplatin 100 + RT(H&N) 1 day | N | N | 270015386 | CISPLATIN + RT |
| 270013654 | 270014324 | 1.71 | 85 | Curative (C) | 2017-01-22 | 2018-05-05 | Rituximab (Maintenance) | 02 | null | 270015386 | RITUXIMAB |
| 270013655 | 270019183 | 1.56 | 44.8 | Disease modification (D) | 2017-09-14 | 2017-10-30 | LEAM | N | Y | 270015390 | LEAM |
| 270013656 | 270009258 | 1.73 | 120 | null | 2017-08-06 | 2017-08-08 | OEPA | 02 | N | 270015393 | OEPA |
| 270013657 | 270009260 | 1.72 | 85 | Disease modification (D) | 2016-12-18 | 2016-12-19 | LEAM | N | N | 270015393 | LEAM |
| 270013658 | 270014326 | 1.65 | 63.5 | Curative (C) | 2017-12-03 | 2017-12-03 | Rituximab | N | N | 270015400 | RITUXIMAB |
| 270013659 | 270009262 | 0 | 108.4 | null | 2015-10-11 | 2015-10-20 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | 270015401 | CETUXIMAB + IRINOTECAN + MDG |
| 270013660 | 270014327 | null | 77 | Curative (C) | 2017-03-24 | 2017-04-22 | Cisplatin + Radiotherapy | N | N | 270015402 | CISPLATIN + RT |
| 270013661 | 270016872 | 1.79 | 55.85 | Curative (C) | 2017-01-03 | 2017-01-07 | LEAM | 02 | N | 270015404 | LEAM |
| 270013662 | 270019184 | null | 82 | Adjuvant (A) | 2014-01-01 | 2014-01-02 | Rituximab | N | N | 270015404 | RITUXIMAB |
| 270013663 | 270014328 | 1.73 | 74 | Palliative (P) | 2016-06-17 | 2016-06-17 | HD EuroNet-PHL-C1 OEPA | N | N | 270015405 | OEPA |
| 270013664 | 270009267 | 1.92 | 108 | Curative (C) | 2018-07-28 | 2018-07-28 | ESHAP | N | N | 270015420 | ESHAP |
| 270013665 | 270018344 | 1.68 | 94.2 | Curative (C) | 2014-06-12 | 2014-06-20 | Cisplatin 100 + RT(H&N) 1 day | N | null | 270015422 | CISPLATIN + RT |
| 270013666 | 270009269 | 1.68 | 71.4 | Palliative (P) | 2017-05-23 | 2017-06-01 | Cetuximab + FOLFIRI cycle1 | N | N | 270015422 | CETUXIMAB + IRINOTECAN + MDG |
| 270013667 | 270018345 | 1.58 | 108.4 | Palliative (P) | 2016-12-10 | 2016-12-17 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | null | 270015429 | CETUXIMAB + IRINOTECAN + MDG |
| 270013668 | 270018345 | 1.54 | 49.8 | Palliative (P) | 2015-07-04 | 2015-07-17 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | 270015429 | CETUXIMAB + IRINOTECAN + MDG |
| 270013669 | 270009270 | 1.82 | 60.3 | Curative (C) | null | 2016-08-20 | ESHAP | N | N | 270015438 | ESHAP |
| 270013670 | 270009272 | 1.76 | 103.8 | Disease modification (D) | 2014-11-05 | 2014-11-14 | Rituximab | N | N | 270015439 | RITUXIMAB |
| 270013671 | 270009273 | 1.62 | 73.15 | Curative (C) | 2017-01-08 | 2017-01-08 | Cisplatin + Radiotherapy | N | N | 270015445 | CISPLATIN + RT |
| 270013672 | 270014332 | 1.8 | 76.3 | Curative (C) | 2013-06-03 | 2013-07-06 | Mini BEAM | 02 | Y | 270015445 | BEAM |
| 270013673 | 270014332 | 1.56 | 56.2 | Palliative (P) | 2016-02-28 | 2016-03-02 | OEPA | N | N | 270015445 | OEPA |
| 270013674 | 270014332 | null | 72.4 | Curative (C) | 2016-11-29 | 2016-11-29 | LEAM | 02 | N | 270015445 | LEAM |
| 270013675 | 270009275 | 1.77 | 113 | Curative (C) | 2017-06-16 | 2017-06-17 | Cisplatin + Radiotherapy | N | N | 270015458 | CISPLATIN + RT |
| 270013676 | 270009276 | 2.14 | 43 | Curative (C) | 2014-03-15 | 2014-03-15 | OEPA | 02 | null | 270015458 | OEPA |
| 270013677 | 270018347 | 1.77 | 36.2 | Disease modification (D) | 2015-05-24 | 2015-05-26 | LEAM | 2 | N | 270015460 | LEAM |
| 270013678 | 270009282 | 1.7 | 69.7 | Disease modification (D) | 2018-09-21 | 2018-09-21 | Rituximab | 02 | N | 270015465 | RITUXIMAB |
| 270013679 | 270009283 | null | 65.8 | null | null | 2015-05-02 | OEPA | 2 | N | 270015465 | OEPA |
| 270013680 | 270009284 | 1.92 | 85.2 | null | 2015-08-02 | 2015-08-02 | Rituximab | N | N | 270015466 | RITUXIMAB |
| 270013681 | 270009284 | 1.77 | 53 | Curative (C) | 2014-04-23 | 2014-04-23 | Rituximab (Maintenance) | 02 | null | 270015466 | RITUXIMAB |
| 270013682 | 270009285 | 1.8 | null | Curative (C) | 2013-09-15 | 2013-12-12 | Rituximab | N | N | 270015472 | RITUXIMAB |